Pharmaceutical composition comprising a SGLT2 inhibitor, a DPP-IV inhibitor and optionally a further antidiabetic agent and uses thereof

Details for Australian Patent Application No. 2010212867 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Eickelmann, Peter; Mark, Michael; Seman, Leo John; Thomas, Leo; Broedl, Uli; Grempler, Rolf

Agent Spruson & Ferguson

Pub. Number AU-A-2010212867

PCT Pub. Number WO2010/092125

Priority 61/152,302 13.02.09 US

Filing date 11 February 2010

Wipo publication date 19 August 2010

International Classifications

A61K 31/00 (2006.01)

A61K 31/06 (2006.01)

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/198 (2006.01)

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/351 (2006.01) - not condensed with another ring

A61K 31/39 (2006.01) - having oxygen atoms in the same ring

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/4439 (2006.01)

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/7004 (2006.01) - Monosaccharides having only carbon, hydrogen and oxygen atoms

A61K 31/7008 (2006.01) - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/08 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/092125 Priority application(s): WO2010/092125

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212868-Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient

2010212866-Pharmaceutical composition comprising linagliptin and optionally a SGLT2 inhibitor, and uses thereof